Cite
[Drug treatment for secondary prevention of myocardial infarction].
MLA
Ishikawa, K., et al. “[Drug Treatment for Secondary Prevention of Myocardial Infarction].” Journal of Cardiology, vol. 35, no. 6, June 2000, pp. 397–408. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10884976&authtype=sso&custid=ns315887.
APA
Ishikawa, K., Kanamasa, K., Hayashi, T., Takenaka, T., Inoki, T., Katayama, K., Miyataka, M., Kimura, A., Yabushita, H., Taniwa, T., & Ikeda, A. (2000). [Drug treatment for secondary prevention of myocardial infarction]. Journal of Cardiology, 35(6), 397–408.
Chicago
Ishikawa, K, K Kanamasa, T Hayashi, T Takenaka, T Inoki, K Katayama, M Miyataka, et al. 2000. “[Drug Treatment for Secondary Prevention of Myocardial Infarction].” Journal of Cardiology 35 (6): 397–408. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=10884976&authtype=sso&custid=ns315887.